NCT02044484

Brief Summary

This research, co-sponsored by the Centers for Disease Control and Prevention and the National Institute of Mental health, is conducted at six HIV clinics in the U.S. The research examines the effect of a clinic-based multi-component intervention delivered to HIV patients when they attend clinic for primary care. The study tests the hypothesis that the intervention will improve the viral load status of patients and improve attendance for HIV primary care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,794

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Jan 2014

Typical duration for not_applicable hiv

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

January 22, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 24, 2014

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

March 20, 2025

Status Verified

March 1, 2025

Enrollment Period

1.4 years

First QC Date

January 22, 2014

Last Update Submit

March 18, 2025

Conditions

Keywords

HIVAIDSViral loadPrimary care

Outcome Measures

Primary Outcomes (2)

  • Percentage of patients with suppressed HIV (≤ 200 copies/mL)

    At 9-month time point

  • Percentage of patients without a gap in HIV primary care (without a gap > 6 months)

    From baseline to 9-month time point

Secondary Outcomes (2)

  • Change across time in log10 viral load values

    From baseline to 9-month time point

  • HIV primary care appointment adherence

    From baseline to 9-month time point

Study Arms (2)

Multi-component intervention

EXPERIMENTAL

Computer-based intervention (CBI) completed twice (separated by 2-4 months) among patients whose viral load exceeds 1000 copies/mL at time of enrollment. One-on-one counseling from a project Health Coach (three 1-hour sessions at the clinic and two follow-up phone calls at 1 and 3 months after last session). The counseling is offered to patients who do not show a 1-log reduction in their viral load after the first CBI or whose viral load remains above 200 copies/mL after two administrations of the CBI. Behavioral screening of patients at HIV primary care visits. Dissemination of palm cards with empowering messages at HIV primary care visits.

Behavioral: Multi-component intervention

Standard of care control

NO INTERVENTION

HIV patients will continue to receive existing standard of care practices at the clinic without receiving the multi-component intervention.

Interventions

The computer-based intervention (CBI) is offered to patients whose viral load exceeds 1000 copies/mL at enrollment. Counseling is offered to patients whose viral load does not drop 1-log after the first CBI or remains above 200 copies/mL after completing two CBIs. The behavioral screener will be conducted of all patients at primary care visits. The patient completes the screener before seeing the provider. Responses are given to their provider who can use it in clinical care of the patient. At primary care visits, all patients are given a palm card containing 1 of 15 empowering messages before they leave the clinic. Messages cover three domains: adhering to antiretroviral therapy, regular care, and safer sex.

Multi-component intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients are eligible to receive behavioral screening and palm cards
  • Patients with viral load exceeding 1000 copies/mL are eligible for the computer-based intervention and referral to counseling

You may not qualify if:

  • Patients under the age of 18 (under 19 in Alabama) are not eligible for the computer-based intervention or referral to counseling because they cannot provide legal informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

1917 Clinic

Birmingham, Alabama, 35294, United States

Location

Owen Clinic

San Diego, California, 92103, United States

Location

Jackson Memorial Hospital

Miami, Florida, 33136, United States

Location

Boston Medical Center

Boston, Massachusetts, 02118, United States

Location

Thomas Street Health Center

Houston, Texas, 77009, United States

Location

Harborview Medical Center

Seattle, Washington, 98104, United States

Location

Related Publications (1)

  • Stirratt MJ, Marks G, O'Daniels C, Cachay ER, Sullivan M, Mugavero MJ, Dhanireddy S, Rodriguez AE, Giordano TP. Characterising HIV transmission risk among US patients with HIV in care: a cross-sectional study of sexual risk behaviour among individuals with viral load above 1500 copies/mL. Sex Transm Infect. 2018 May;94(3):206-211. doi: 10.1136/sextrans-2017-053178. Epub 2017 Nov 2.

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Thomas P Giordano, MD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR
  • Margaret Sullivan, MD

    Boston University

    PRINCIPAL INVESTIGATOR
  • Matthew Golden, MD

    University of Washington

    PRINCIPAL INVESTIGATOR
  • Edward Cachay, MD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR
  • Michael J Mugavero, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
  • Allan E Rodriguez, MD

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2014

First Posted

January 24, 2014

Study Start

January 1, 2014

Primary Completion

June 1, 2015

Study Completion

October 1, 2016

Last Updated

March 20, 2025

Record last verified: 2025-03

Locations